Glanbia PLC (GL9) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Glanbia PLC (GL9) has a cash flow conversion efficiency ratio of 0.020x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€40.70 Million ≈ $47.58 Million USD) by net assets (€2.01 Billion ≈ $2.35 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Glanbia PLC - Cash Flow Conversion Efficiency Trend (1991–2024)
This chart illustrates how Glanbia PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Glanbia PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Glanbia PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX
|
0.144x |
|
Navin Fluorine International Limited
NSE:NAVINFLUOR
|
0.078x |
|
GZ Port
SHG:601228
|
0.010x |
|
Olav Thon Eien
OL:OLT
|
0.000x |
|
Nelnet Inc
NYSE:NNI
|
0.031x |
|
Maximus Inc
NYSE:MMS
|
-0.142x |
|
Garden Reach Shipbuilders & Engineers Limited
NSE:GRSE
|
-0.263x |
|
Pan African Resources PLC
JSE:PAN
|
0.064x |
Annual Cash Flow Conversion Efficiency for Glanbia PLC (1991–2024)
The table below shows the annual cash flow conversion efficiency of Glanbia PLC from 1991 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €2.07 Billion ≈ $2.42 Billion |
€443.20 Million ≈ $518.15 Million |
0.214x | +6.59% |
| 2023-12-31 | €2.13 Billion ≈ $2.49 Billion |
€427.80 Million ≈ $500.14 Million |
0.201x | +25.65% |
| 2022-12-31 | €1.87 Billion ≈ $2.18 Billion |
€298.30 Million ≈ $348.74 Million |
0.160x | +10.65% |
| 2021-12-31 | €1.74 Billion ≈ $2.03 Billion |
€251.10 Million ≈ $293.56 Million |
0.144x | -16.16% |
| 2020-12-31 | €1.61 Billion ≈ $1.88 Billion |
€277.40 Million ≈ $324.31 Million |
0.172x | +37.84% |
| 2019-12-31 | €1.70 Billion ≈ $1.99 Billion |
€212.50 Million ≈ $248.43 Million |
0.125x | -27.88% |
| 2018-12-31 | €1.59 Billion ≈ $1.86 Billion |
€275.10 Million ≈ $321.62 Million |
0.173x | +162.56% |
| 2017-12-31 | €1.38 Billion ≈ $1.62 Billion |
€91.10 Million ≈ $106.51 Million |
0.066x | -74.95% |
| 2016-12-31 | €1.23 Billion ≈ $1.43 Billion |
€322.91 Million ≈ $377.51 Million |
0.263x | +1.10% |
| 2015-12-31 | €1.06 Billion ≈ $1.24 Billion |
€276.71 Million ≈ $323.51 Million |
0.260x | +20.63% |
| 2014-12-31 | €804.78 Million ≈ $940.87 Million |
€173.65 Million ≈ $203.01 Million |
0.216x | +28.88% |
| 2013-12-31 | €643.52 Million ≈ $752.34 Million |
€107.74 Million ≈ $125.96 Million |
0.167x | +24.83% |
| 2012-12-31 | €544.66 Million ≈ $636.76 Million |
€73.05 Million ≈ $85.40 Million |
0.134x | -31.85% |
| 2011-12-31 | €522.95 Million ≈ $611.38 Million |
€102.92 Million ≈ $120.32 Million |
0.197x | +19.93% |
| 2010-12-31 | €424.40 Million ≈ $496.17 Million |
€69.65 Million ≈ $81.42 Million |
0.164x | -28.96% |
| 2009-12-31 | €297.39 Million ≈ $347.68 Million |
€68.69 Million ≈ $80.31 Million |
0.231x | -41.56% |
| 2008-12-31 | €227.92 Million ≈ $266.46 Million |
€90.08 Million ≈ $105.32 Million |
0.395x | +49.31% |
| 2007-12-31 | €234.57 Million ≈ $274.24 Million |
€62.10 Million ≈ $72.60 Million |
0.265x | +52.61% |
| 2006-12-31 | €200.52 Million ≈ $234.43 Million |
€34.78 Million ≈ $40.66 Million |
0.173x | -84.32% |
| 2005-12-31 | €123.72 Million ≈ $144.64 Million |
€136.88 Million ≈ $160.03 Million |
1.106x | +279.99% |
| 2004-12-31 | €230.29 Million ≈ $269.24 Million |
€67.05 Million ≈ $78.39 Million |
0.291x | +105.13% |
| 2003-12-31 | €298.04 Million ≈ $348.44 Million |
€42.30 Million ≈ $49.46 Million |
0.142x | -40.14% |
| 2002-12-31 | €320.44 Million ≈ $374.62 Million |
€75.99 Million ≈ $88.84 Million |
0.237x | -31.77% |
| 2001-12-31 | €322.76 Million ≈ $377.34 Million |
€112.18 Million ≈ $131.15 Million |
0.348x | +27.05% |
| 2000-12-31 | €289.72 Million ≈ $338.72 Million |
€79.26 Million ≈ $92.66 Million |
0.274x | +115.64% |
| 1999-12-31 | €272.70 Million ≈ $318.81 Million |
€34.59 Million ≈ $40.45 Million |
0.127x | -60.16% |
| 1998-12-31 | €216.29 Million ≈ $252.87 Million |
€68.88 Million ≈ $80.53 Million |
0.318x | +22.10% |
| 1997-12-31 | €188.46 Million ≈ $220.33 Million |
€49.15 Million ≈ $57.46 Million |
0.261x | +68.36% |
| 1996-12-31 | €294.46 Million ≈ $344.25 Million |
€45.61 Million ≈ $53.33 Million |
0.155x | -51.24% |
| 1995-12-31 | €194.37 Million ≈ $227.24 Million |
€61.74 Million ≈ $72.19 Million |
0.318x | +61.55% |
| 1994-12-31 | €170.04 Million ≈ $198.80 Million |
€33.44 Million ≈ $39.09 Million |
0.197x | -56.69% |
| 1993-12-31 | €120.61 Million ≈ $141.00 Million |
€54.76 Million ≈ $64.01 Million |
0.454x | +304.77% |
| 1992-12-31 | €121.16 Million ≈ $141.65 Million |
€13.59 Million ≈ $15.89 Million |
0.112x | -12.06% |
| 1991-12-31 | €138.35 Million ≈ $161.74 Million |
€17.64 Million ≈ $20.63 Million |
0.128x | -- |
About Glanbia PLC
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes produ… Read more